George P. Canellos

26.4k total citations · 4 hit papers
209 papers, 15.8k citations indexed

About

George P. Canellos is a scholar working on Pathology and Forensic Medicine, Oncology and Genetics. According to data from OpenAlex, George P. Canellos has authored 209 papers receiving a total of 15.8k indexed citations (citations by other indexed papers that have themselves been cited), including 104 papers in Pathology and Forensic Medicine, 75 papers in Oncology and 52 papers in Genetics. Recurrent topics in George P. Canellos's work include Lymphoma Diagnosis and Treatment (102 papers), Chronic Lymphocytic Leukemia Research (44 papers) and Lung Cancer Treatments and Mutations (37 papers). George P. Canellos is often cited by papers focused on Lymphoma Diagnosis and Treatment (102 papers), Chronic Lymphocytic Leukemia Research (44 papers) and Lung Cancer Treatments and Mutations (37 papers). George P. Canellos collaborates with scholars based in United States, United Kingdom and Australia. George P. Canellos's co-authors include Vincent T. DeVita, Emil Frei, Robert C. Young, Richard I. Fisher, Margaret A. Shipp, Joseph M. Connors, Tim Lister, Arthur T. Skarin, B. A. Peterson and Bruce D. Cheson and has published in prestigious journals such as New England Journal of Medicine, Circulation and Journal of Clinical Investigation.

In The Last Decade

George P. Canellos

208 papers receiving 14.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Report of an International Workshop to Standardize Response Criteria for Non-Hodgkin's Lymphomas

1999 2.8k citations Bruce D. Cheson, Margaret A. Shipp et al. Journal of Clinical Oncology profile →
Chemotherapy of Advanced Hodgkin's Disease with MOPP, ABVD, or MOPP Alternating with ABVD

1992 813 citations George P. Canellos, B. A. Peterson et al. New England Journal of Medicine profile →
Meta-analysis of radiation therapy with and without adjuvant chemotherapy for malignant gliomas in adults

1993 689 citations George P. Canellos et al. Cancer profile →
Dose: A critical factor in cancer chemotherapy

1980 652 citations George P. Canellos et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
George P. Canellos United States	64	8.0k	6.0k	3.8k	3.2k	2.8k	209	15.8k
Sandra J. Horning United States	62	13.9k 1.7×	10.4k 1.7×	4.5k 1.2×	3.1k 1.0×	4.1k 1.5×	228	19.4k
Gianni Bonadonna Italy	75	7.5k 0.9×	11.3k 1.9×	2.2k 0.6×	3.9k 1.2×	2.1k 0.7×	373	20.2k
Andreas Engert Germany	72	12.1k 1.5×	9.2k 1.5×	4.1k 1.1×	3.3k 1.0×	4.5k 1.6×	552	20.7k
Jamés O. Armitage United States	74	15.9k 2.0×	12.4k 2.1×	6.2k 1.6×	2.9k 0.9×	4.5k 1.6×	487	25.6k
Franco Cavalli Switzerland	43	7.7k 1.0×	5.0k 0.8×	2.7k 0.7×	2.0k 0.6×	3.2k 1.1×	190	11.6k
Pierre Biron France	50	4.5k 0.6×	4.7k 0.8×	2.0k 0.5×	1.7k 0.5×	2.3k 0.8×	292	10.6k
Richard Sposto United States	67	2.8k 0.3×	3.4k 0.6×	4.2k 1.1×	2.0k 0.6×	3.9k 1.4×	282	13.4k
Richard I. Fisher United States	73	18.9k 2.3×	16.2k 2.7×	6.2k 1.6×	5.0k 1.6×	5.8k 2.0×	333	31.5k
Lois B. Travis United States	62	3.4k 0.4×	4.8k 0.8×	1.2k 0.3×	3.4k 1.1×	1.1k 0.4×	183	14.0k
D. Crowther United Kingdom	50	3.2k 0.4×	4.7k 0.8×	1.1k 0.3×	2.0k 0.6×	1000 0.4×	178	9.3k

Countries citing papers authored by George P. Canellos

Since Specialization

Citations

This map shows the geographic impact of George P. Canellos's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by George P. Canellos with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites George P. Canellos more than expected).

Fields of papers citing papers by George P. Canellos

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by George P. Canellos. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by George P. Canellos. The network helps show where George P. Canellos may publish in the future.

Co-authorship network of co-authors of George P. Canellos

This figure shows the co-authorship network connecting the top 25 collaborators of George P. Canellos. A scholar is included among the top collaborators of George P. Canellos based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with George P. Canellos. George P. Canellos is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Kostakoğlu, Lale, Heiko Schöder, Jeffrey L. Johnson, et al.. (2012). Interim [¹⁸F]fluorodeoxyglucose positron emission tomography imaging in stage I–II non-bulky Hodgkin lymphoma: would using combined positron emission tomography and computed tomography criteria better predict response than each test alone?. Leukemia & lymphoma. 53(11). 2143–2150. 31 indexed citations

Wilson, Wyndham H., Sin‐Ho Jung, Pierluigi Porcu, et al.. (2011). A Cancer and Leukemia Group B multi-center study of DA-EPOCH-rituximab in untreated diffuse large B-cell lymphoma with analysis of outcome by molecular subtype. Haematologica. 97(5). 758–765. 125 indexed citations

Canellos, George P., Jeremy S. Abramson, David C. Fisher, & Ann S. LaCasce. (2010). Treatment of Favorable, Limited-Stage Hodgkin's Lymphoma With Chemotherapy Without Consolidation by Radiation Therapy. Journal of Clinical Oncology. 28(9). 1611–1615. 39 indexed citations

Barnes, Jeffrey A., Ann S. LaCasce, Katherine Zukotynski, et al.. (2010). End-of-treatment but not interim PET scan predicts outcome in nonbulky limited-stage Hodgkin’s lymphoma. Annals of Oncology. 22(4). 910–915. 72 indexed citations

Smith, Sonali M., Bruce D. Cheson, George P. Canellos, et al.. (2009). Recombinant interferon-α2b added to oral cyclophosphamide either as induction or maintenance in treatment-naive follicular lymphoma: final analysis of CALGB 8691. Leukemia & lymphoma. 50(10). 1606–1617. 5 indexed citations

Canellos, George P., et al.. (2009). Intensity of Renal Support in Critically Ill Patients with Acute Kidney Injury. New England Journal of Medicine. 361(24). 2391–2391. 63 indexed citations

Armand, Philippe, Haesook T. Kim, Corey Cutler, et al.. (2008). Improved Survival in Lymphoma Patients Receiving Sirolimus for Graft-Versus-Host Disease Prophylaxis After Allogeneic Hematopoietic Stem-Cell Transplantation With Reduced-Intensity Conditioning. Journal of Clinical Oncology. 26(35). 5767–5774. 80 indexed citations

Peterson, B. A., Jeffrey L. Johnson, Margaret A. Shipp, et al.. (2007). High dose CHOP: A phase II study of initial treatment in aggressive non-Hodgkin lymphoma. Cancer and Leukemia Group B 9351. Leukemia & lymphoma. 48(5). 870–880. 2 indexed citations

Canellos, George P.. (2007). Relapsed and Refractory Hodgkin's Lymphoma: New Avenues?. Hematology/Oncology Clinics of North America. 21(5). 929–941. 5 indexed citations

10.

Czuczman, Myron S., Pierluigi Porcu, Jeffrey L. Johnson, et al.. (2007). Results of a phase II study of 506U78 in cutaneous T-cell lymphoma and peripheral T-cell lymphoma: CALGB 59901. Leukemia & lymphoma. 48(1). 97–103. 29 indexed citations

11.

Janícek, M, William D. Kaplan, Donna Neuberg, et al.. (1997). Early restaging gallium scans predict outcome in poor-prognosis patients with aggressive non-Hodgkin's lymphoma treated with high-dose CHOP chemotherapy.. Journal of Clinical Oncology. 15(4). 1631–1637. 77 indexed citations

12.

Canellos, George P.. (1994). ASCO 30 years later: the state of the Society.. Journal of Clinical Oncology. 12(11). 2510–2513. 1 indexed citations

13.

Tarbell, N J, Barbara Silver, C. Norman Coleman, et al.. (1993). Wide-field radiation therapy with or without chemotherapy for patients with Hodgkin disease in relapse after initial combination chemotherapy. Cancer. 72(1). 207–212. 30 indexed citations

14.

Canellos, George P.. (1987). The case for high-dose chemotherapy: Is it chemotherapy's last gamble?. European Journal of Cancer and Clinical Oncology. 23(4). 351–355. 5 indexed citations

15.

Li, Frederick P., et al.. (1981). Breast cancer after hodgkin's disease in two sisters. Cancer. 47(1). 200–202. 25 indexed citations

16.

Parker, L M, C. Thomas Griffiths, Ronald A. Yankee, R. C. Knapp, & George P. Canellos. (1979). High-dose methotrexate with leucovorin rescue in ovarian cancer: a phase II study.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 63(2). 275–9. 14 indexed citations

17.

Canellos, George P., Vincent T. DeVita, G. Lennard Gold, et al.. (1974). Cyclical Combination Chemotherapy for Advanced Breast Carcinoma. BMJ. 1(5901). 218–220. 83 indexed citations

18.

Canellos, George P., Jacqueline Whang‐Peng, Lowell E. Schnipper, & Clarence H. Brown. (1972). Prolonged cytogenetic and hematologic remission of blastic transformation in chronic granulogytic leukemia. Cancer. 30(1). 288–293. 18 indexed citations

19.

Canellos, George P., M. Patterson, Geoffrey Neale, & M. C. Brain. (1967). Phenacetin induced heinz body formation in rats with intestinal blind loops abstract. British Journal of Haematology. 13(5). 808. 1 indexed citations

20.

Canellos, George P., J. A. R. Mead, Nathaniel H. Greenberg, & Anthony W. Schrecker. (1967). The effect of treatment with cytotoxic agents on mouse spleen dihydrofolate reductase activity.. PubMed. 27(4). 784–8. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact